Chi-Shin Wu, PhD

National Center for Geriatrics and Welfare Research, National Health Research Institutes, Yunlin, Taiwan; Department of Psychiatry, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan

  • 7Articles
  • 33.6KReads
  • 2013–2026Active
  • 25Collaborators
  • 168Citations

About

Chi-Shin Wu, PhD, is affiliated with the National Center for Geriatrics and Welfare Research at the National Health Research Institutes and the Department of Psychiatry at National Taiwan University Hospital Yunlin Branch. Wu has authored multiple articles from 2013 to 2026 focusing on clinical topics including schizophrenia, schizoaffective disorders, major depressive disorder, dementia, geriatric psychiatry, and suicide prevention. Research contributions include studies on the risks associated with antipsychotic and antidepressant treatments, autoimmune diseases and dementia risk, and interventions for self-harm and suicide. Wu frequently collaborates with co-authors Hui-Ju Tsai, Chia-Ming Chang, Shi-Kai Liu, Ya-Wen Huang, and Chao-Cheng Lin.

Publications

JCP
Effect of a Nationwide Aftercare Program for Self-Harm Presentations on the Risk of Self-Harm Repetition and Suicide
Original Research

Effect of a Nationwide Aftercare Program for Self-Harm Presentations on the Risk of Self-Harm Repetition and Suicide

May 20, 2026

Aftercare following self-harm was associated with increased risk of repeat self-harm hospital presentation and decreased risk of suicide.
, , , et al
JCP
Autoimmune Diseases, Treatments, and Dementia Risk: A Population-Based Case-Control Study from Taiwan
Original Research

Autoimmune Diseases, Treatments, and Dementia Risk: A Population-Based Case-Control Study from Taiwan

October 15, 2025

Thirteen autoimmune diseases were linked with an elevated dementia risk, particularly Behçet's disease, multiple sclerosis, and lupus. Associations with vascular dementia were stronger than with Alzheimer's disease.
, , , et al
JCP
Original Research

Seizure Risk of Antidepressants

October 24, 2017

Do second-generation antidepressants pose an increased risk of seizure? These authors used Taiwan's national health insurance database to investigate the question, including whether dose or medication class affects the...
, , , et al
JCP
Original Research

Comparative Risk of Antipsychotic-Related Seizure

May 25, 2016

Seizure risk can influence whether you choose an FGA or SGA for your patients with schizophrenia or mood disorders. This analytical review of seizure events in almost 300,000 new...
, , , et al
JCP
Original Research

Antipsychotic Treatment and the Risk of Hip Fracture in Subjects With Schizophrenia: A 10-Year Population-Based Case-Control Study

September 23, 2015

, , , et al
JCP
Article

Long-Term Antidepressant Use and the Risk of Type 2 Diabetes Mellitus: A Population-Based, Nested Case-Control Study in Taiwan

January 15, 2014

, ,
JCP
Original Research

Antipsychotic Treatment and the Occurrence of Venous Thromboembolism: A 10-Year Nationwide Registry Study

September 15, 2013

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe